Advanced Therapy Medicinal Products Market

Report Highlights

The report broadly covers different types of advanced therapy medicinal products based on their therapy type. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for Advanced Therapy Medicinal Products market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each therapy type, diseases, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional advanced therapy medicinal products markets; it explains the major market drivers of the global advanced therapy medicinal products industry, current trends within the industry, major applications, and the regional dynamics of the global advanced therapy medicinal products market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global advanced therapy medicinal products market.

Report Includes

• 29 tables and 37 figures
• An up-to-date analysis of the Global Advanced Therapy Medicinal Products Market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for Global Advanced Therapy Medicinal Products Market, and corresponding market share analysis by therapy type, diseases, and region.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Advanced Therapy Medicinal Products, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of promising new products still in the development and testing stages, and their probability of successful commercial launch within the next five years
• Impact of COVID-19 on the Advanced Therapy Medicinal Products Market as compared to overall global economy.
• Insight into the growth development strategies of major Advanced Therapy Medicinal Products manufacturers and their key competitive landscape
• Descriptive company profiles of the leading market participants, including Spark Therapeutics, Inc., bluebird bio, Inc., Novartis International AG, UniQure N.V., Bristol-Myers Squibb Company, Gilead Lifesciences, Inc., Vericel Corporation G, and others.

Summary

Advanced Therapy Medicinal Products (ATMPs) are pioneering treatments that includes tissue engineered products, cell therapy and gene therapy. Cell therapy products consist of cellular immunotherapies and autologous and allogeneic cells for specific medicinal indications including mature and embryonic stem cells. Whereas human gene therapy belongs to products that establish genomic material into people’s DNA to substitute faulty or absent genetic material, thus curing a disease or irregular medical condition.

These are a unique class of drugs that offer potential therapy prospects for diseases that have presently limited or no medicinal options such as metabolic disorders, hemophilia, muscular dystrophies, cystic fibrosis, skin burns, Alzheimer, and even cancer.